Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
Twenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen α1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure−activity relationship (SAR) indicated that the introduction of a benzyl...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/4/773 |
id |
doaj-ffd817eb7f704af29d7fabef2fcd93b6 |
---|---|
record_format |
Article |
spelling |
doaj-ffd817eb7f704af29d7fabef2fcd93b62020-11-25T02:03:23ZengMDPI AGMolecules1420-30492020-02-0125477310.3390/molecules25040773molecules25040773Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 PathwaysTianyun Fan0Maoxu Ge1Zhihao Guo2Hongwei He3Na Zhang4Yinghong Li5Danqing Song6Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaTwenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen α1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure−activity relationship (SAR) indicated that the introduction of a benzyl motif on the 9<i>O</i> atom was favorable for activity. Among them, compound <b>6c</b> provided the highest inhibitory effect against COL1A1 with an IC<sub>50</sub> value of 3.98 μM, and it also dose-dependently inhibited the expression of fibrogenic COL1A1, α-soomth muscle actin (α-SMA), matrix metalloprotein 2 (MMP2) in both mRNA and protein levels, indicating extensive inhibitory activity against fibrogenesis. A further primary mechanism study indicated that it might repress the hepatic fibrogenesis via inhibiting both canonical transforming growth factor-beta 1 (TGF-β1)/Smads and non-canonical janus-activated kinase 1 (JAK1)/singal transducer and activator of transcription 3 (STAT3) signaling pathways. Additionally, <b>6c</b> owned a high safety profile with the LD<sub>50</sub> value of over 1000 mg·kg<sup>−1</sup> in mice. These results identified palmatine derivatives as a novel class of anti-fibrogenic agents, and provided powerful information for further structure optimization.https://www.mdpi.com/1420-3049/25/4/773hepatic fibrosispalmatinestructure−activity relationshipcol1a1tgf-β1/smads pathwayjak1/stat3 pathway |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tianyun Fan Maoxu Ge Zhihao Guo Hongwei He Na Zhang Yinghong Li Danqing Song |
spellingShingle |
Tianyun Fan Maoxu Ge Zhihao Guo Hongwei He Na Zhang Yinghong Li Danqing Song Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways Molecules hepatic fibrosis palmatine structure−activity relationship col1a1 tgf-β1/smads pathway jak1/stat3 pathway |
author_facet |
Tianyun Fan Maoxu Ge Zhihao Guo Hongwei He Na Zhang Yinghong Li Danqing Song |
author_sort |
Tianyun Fan |
title |
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways |
title_short |
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways |
title_full |
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways |
title_fullStr |
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways |
title_full_unstemmed |
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways |
title_sort |
discovery of 9<i>o</i>-substituted palmatine derivatives as a new class of anti-col1a1 agents via repressing tgf-β1/smads and jak1/stat3 pathways |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2020-02-01 |
description |
Twenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen α1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure−activity relationship (SAR) indicated that the introduction of a benzyl motif on the 9<i>O</i> atom was favorable for activity. Among them, compound <b>6c</b> provided the highest inhibitory effect against COL1A1 with an IC<sub>50</sub> value of 3.98 μM, and it also dose-dependently inhibited the expression of fibrogenic COL1A1, α-soomth muscle actin (α-SMA), matrix metalloprotein 2 (MMP2) in both mRNA and protein levels, indicating extensive inhibitory activity against fibrogenesis. A further primary mechanism study indicated that it might repress the hepatic fibrogenesis via inhibiting both canonical transforming growth factor-beta 1 (TGF-β1)/Smads and non-canonical janus-activated kinase 1 (JAK1)/singal transducer and activator of transcription 3 (STAT3) signaling pathways. Additionally, <b>6c</b> owned a high safety profile with the LD<sub>50</sub> value of over 1000 mg·kg<sup>−1</sup> in mice. These results identified palmatine derivatives as a novel class of anti-fibrogenic agents, and provided powerful information for further structure optimization. |
topic |
hepatic fibrosis palmatine structure−activity relationship col1a1 tgf-β1/smads pathway jak1/stat3 pathway |
url |
https://www.mdpi.com/1420-3049/25/4/773 |
work_keys_str_mv |
AT tianyunfan discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT maoxuge discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT zhihaoguo discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT hongweihe discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT nazhang discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT yinghongli discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways AT danqingsong discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways |
_version_ |
1724948668549693440 |